You are here: Industry Insights > 2024

News List

Frost & Sullivan Defines Top Femtech Global Opportunities by 2024 prnasia
March 03, 2020
In an era where the healthcare industry is moving toward personalized care solutions and the acknowledgment of inherent biological differences, the femtech (female technology) market revenue is expected to reach $1.1 billion by 2024, growing at a compound
Global APIs market predicted to reach $245.2 billion by 2024 europeanpharmaceuticalreview
January 08, 2019
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals…
Top 20 Companies by Global Prescription Drug Sales in 2024 Weiyi
December 14, 2018
According to the forecast of EvaluatePharma, the pharmaceutical market is going out of the sluggish state following the financial crisis and accelerating growth, to an compound annual growth rate (CAGR) of 6% between now and 2024.
The top 10 drugmakers of 2024 fiercepharma
September 26, 2018
Big Pharma will get bigger, much bigger, over the next several years, with the companies vying to grow their sales in a range of established and emerging therapeutic areas, notably cancer and immunology.
The TOP 5 CV Drugs for 2017 to 2024 fiercepharma
August 27, 2018
The cardiovascular scene to shift by 2024 as next-gen drugs like Eliquis and Xarelto eclipse stalwarts
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024 fiercepharma
June 08, 2018
Even as many things change in the drug industry, at least one fact should stay the same in the coming years, according to analysts at EvaluatePharma.